Evidence to show HLA-linked susceptibility to rheumatic heart disease.

B. Jhinghan, M. C. Vaidya, Shubhika Srivastava(Nemours Children's Health System), Manvir Bhatia, K. Srinath Reddy(Rashtreeya Sikshana Samithi Trust), Rushama Tandon, NK Mehra(Indian Institute of Management Ahmedabad), Veena Taneja(Mayo Clinic)
PubMed
December 1, 1988
Cited by 0

Related Papers

Food in the Anthropocene: the EAT–Lancet Commission on healthy diets from sustainable food systems
|The Lancet|2019|10.6k
Priority actions for the non-communicable disease crisis
|The Lancet|2011|1.6k
Sex Hormones Determine Immune Response
|Frontiers in Immunology|2018|572
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
|The Lancet|2022|407
The burden of chronic respiratory diseases and their heterogeneity across the states of India: the Global Burden of Disease Study 1990–2016
|The Lancet Global Health|2018|380